ClinicalTrials.Veeva

Menu

The Effect of Topical Curcumin Versus Topical Corticosteroid on Management of Oral Lichen Planus Patients

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Unknown
Phase 1

Conditions

Oral Lichen Planus

Treatments

Drug: Triamcinolone
Drug: Turmeric paste

Study type

Interventional

Funder types

Other

Identifiers

NCT03877679
OMED2:5:1

Details and patient eligibility

About

Introduce a new anti-inflammatory and antioxidant paste preparation (curcumin paste) in the management of Oral lichen planus.

  • Assess the efficacy of this preparation on pain, clinical parameter and the level of IL-33 in saliva.
  • Compare the outcome of new preparation with the gold standard treatment (corticosteroids).

Full description

Two groups will be prepared then decision of which one take curcumin paste will be selected according to randomized numbers in a sequentially numbered, opaque, sealed envelope

1 group will take topical corticosteroid and 1 will take curcumin paste then IL-33 level in saliva will be measured at the base line and at the end of 4th week pain and clinical parameters will be measured at 2nd and 4th week

Enrollment

40 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients who will be clinically diagnosed as having atrophic &/or erosive oral lichen planus.
  • Patients with controlled diabetes and/or controlled hypertension will be included in the study.
  • Patients with no history of taking corticosteroids for the last 6 months
  • Patients who agrees to take medication.

Exclusion criteria

  • Pregnant and lactating ladies.
  • Patients with history of topical steroids during last 2 months & systemic steroids during last 6 months.
  • Patients with recent dental filling associated with the lesion or associated with recent drug administration.
  • Patient with uncontrolled diabetes, uncontrolled hypertension, or those with positive HCV ab or HBs Ag.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

turmeric paste
Experimental group
Description:
Topical curcumin gel (a mixture of curcumin powder and vegetable glycerin base in a ratio of 1:8 by weight) Mix with 85ml carbapol gel (125ml H2O + 0.5g carbapol + triethanolamine 3 drops) prepared in the Faculty of pharmacy-Cairo University traumeric extracted from Curcuma plant, it has anti-inflammatory, antioxidative and antineoplastic properties ((Nosratzehi et al., 2018), The curcumin is safe even in high doses, Since oxidative stress may play a role in pathophysiology of OLP, and by noting that OLP is a chronic inflammatory disease, the herbs which have both anti-inflammatory and antioxidant properties may efficiently control OLP (Kia et al., 2015).
Treatment:
Drug: Turmeric paste
Triamcenolone in orabase
Active Comparator group
Description:
Triamcenolone + na ploycarboxylate
Treatment:
Drug: Triamcinolone

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems